InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Browse the complete record of transactions filed by Schall Thomas J., Chairman & CEO. Insider active across 1 companies, notably ChemoCentryx, Inc.. Aggregated, 4 disclosures have been recorded. The latest transaction was filed on 1 January 2022 — Levée d'options. Regulator: SEC (Form 4). The full history is openly available.
Declarations4 total
023,334 shares0
Common Stock
SEC:0001209191-22-001341·
023,334 shares0
Common Stock
SEC:0001209191-22-001341:0·
€353,03238,948 shares@ €9.06420.062% mcap100.0% of flow
Common Stock
SEC:0001209191-21-068010·
€353,03238,948 shares@ €9.06420.062% mcap50.0% of flow
Common Stock
SEC:0001209191-21-068010:0·
4 of 4 declarations
About Schall Thomas J.
Schall Thomas J. is the President and CEO of ChemoCentryx, Inc. He leads the company in developing innovative treatments for autoimmune diseases, overseeing operations and research strategy.
